RxDoctor Payments Data

Bobbi Sanders

Family · Tupelo, MSNPI 1396150017

Payments from drug & device makers

$1,526in general payments, 2019–2025

Across 78 payments — averaging $19.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$443
  • Medtronic$411
  • Amgen$71
  • AbbVie$68
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$61
  • United Therapeutics Corporation$56
  • plus $416 from 16 others

What the payments were for

  • Food & beverage$1,526100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,526 in reported general payments places this provider in the 75th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi

Medicare billing

Part B allowed, 2024
$67,606
Medicare patients
248
Services billed
1,946

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin11$6,322
SynthroidLevothyroxine Sodium22$2,365
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen63$1,578
Potassium Chloride69$1,424
Levothyroxine Sodium95$926
Gabapentin55$826
Losartan Potassium99$666
Amlodipine Besylate119$585
Albuterol Sulfate HfaAlbuterol Sulfate16$578
Atorvastatin Calcium103$555
Metoprolol Succinate40$503
Ezetimibe20$498
Lisinopril50$490
Duloxetine Hcl17$476
Escitalopram Oxalate64$473

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$47$6,32211 claims
AbbVieSynthroid$68$2,36522 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,007 family providers in Mississippi.

Other family in Tupelo

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →